Ocular Inflammation in Behçet Disease: Incidence of Ocular Complications and of Loss of Visual Acuity

American Journal of Ophthalmology

Volumn 146, Issue 6, 2008, Pages 828-836

  Kaçmaz, R Oktay ^a   Kempen, John H ^b,c,d   Newcomb, Craig ^b,d   Gangaputra, Sapna ^e   Daniel, Ebenezer ^e   Levy Clarke, Grace A ^g   Nussenblatt, Robert B ^g   Rosenbaum, James T ^h   Suhler, Eric B ^h,i   Thorne, Jennifer E ^e,f   Jabs, Douglas A ^e   Foster, C Stephen ^a,j  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g NATIONAL EYE INSTITUTE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ PORTLAND VA MEDICAL CENTER   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CHILD; COHORT ANALYSIS; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UVEITIS, ANTERIOR; UVEITIS, POSTERIOR; VISION DISORDERS; VISUAL ACUITY; YOUNG ADULT;

EID: 56249131741     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.06.019     Document Type: Article

References (28)

1. Behçet H. Uber rezidivierende Aphtose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105 (1937) 1152-1157
2. Foster C.S. Diagnosis and Treatment of Uveitis (2001), WB Saunders, Philadelphia, Pennsylvania 632-652
3. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
4. Verity D.H., Wallace G.R., Vaughan R.W., and Stanford M.R. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 87 (2003) 1175-1183
5. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50 (2005) 297-350
6. Kempen J.H., Daniel E., Gangaputra S., et al., Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol 15 (2008) 47-55
7. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T., et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140 (2005) 509-516
8. Kempen J.H., Jabs D.A., Wilson L.A., Dunn J.P., West S.K., and Tonascia J.A. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 121 (2003) 466-476
9. Lin D.Y., and Wei L.J. The robust inference for the Cox proportional hazards model. J Am Stat Association 84 (1989) 1074-1078
10. Mamo J.G. The rate of visual loss in Behçet's disease. Arch Ophthalmol 84 (1970) 451-452
11. Boyd S.R., Young S., and Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 46 (2001) 209-233
12. Michelson J.B., and Chisari F.V. Behçet's disease. Surv Ophthalmol 26 (1982) 190-203
13. Muhaya M., Lightman S., Ikeda E., et al. Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8 (2000) 141-148
14. Kitaichi N., Miyazaki A., Iwata D., Ohno S., Stanford M.R., and Chams H. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol 91 (2007) 1579-1582
15. Yoshida A., Kawashima H., Motoyama Y., et al. Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 111 (2004) 810-815
16. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., Huseyin Altunbas H., and Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138 (2004) 373-380
17. Keino H., and Okada A.A. Behçet's disease: global epidemiology of an Old Silk Road disease. Br J Ophthalmol 91 (2007) 1573-1574
18. Krause I., Yankevich A., Fraser A., et al. Prevalence and clinical aspects of Behçet's disease in the North of Israel. Clin Rheumatol 26 (2007) 555-560
19. Salvarani C., Pipitone N., Catanoso M.G., et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57 (2007) 171-178
20. Sakamoto M., Akazawa K., Nishioka Y., Sanui H., Inomata H., and Nose Y. Prognostic factors of vision in patients with Behçet disease. Ophthalmology 102 (1995) 317-321
21. Takeuchi M., Hokama H., Tsukahara R., et al. Risk and prognostic factors of poor visual outcome in Behçet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243 (2005) 1147-1152
22. Yazici H., Pazarli H., Barnes C.G., et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322 (1990) 281-285
23. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., and Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1 (1989) 1093-1096
24. Durrani K., Ahmed M., and Foster C.S. Adamantiades-Behçet disease: diagnosis and current concepts in management of ocular manifestations. Compr Ophthalmol Update 8 (2007) 225-233
25. Accorinti M., Pirraglia M.P., Paroli M.P., Priori R., Conti F., and Pivetti-Pezzi P. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease. Jpn J Ophthalmol 51 (2007) 191-196
26. Takamoto M., Kaburaki T., Numaga J., Fujino Y., and Kawashima H. Long-term infliximab treatment for Behçet's disease. Jpn J Ophthalmol 51 (2007) 239-240
27. Kotter I., Gunaydin I., Zierhut M., and Stubiger N. The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum 33 (2004) 320-335
28. Demiroglu H., Barista I., and Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 104 (1997) 701-705